Minerva Surgical, Inc. (UTRS)
Minerva Surgical, Inc. functions as a commercial-stage medical technology enterprise, specializing in the creation, production, and distribution of innovative, minimally invasive solutions tailored to address the uterine healthcare needs of women throughout the United States. Their suite of offerings features advanced endometrial ablation systems, including the Minerva ES and Genesys HTA. They also provide the Symphion Tissue Removal System, a sophisticated, minimally invasive device for uterine tissue removal that uniquely integrates bladeless tissue resection, coagulation capabilities, continuous visualization during procedures, and precise intrauterine pressure monitoring. Additionally, the Resectr Tissue Resection Device is a handheld surgical tool engineered for the hysteroscopic removal and diagnostic evaluation of endometrial polyps. These specialized instruments are utilized by obstetrician-gynecologists across a variety of clinical settings, such as hospitals, outpatient ambulatory surgical centers, and private physician practices. The company was founded in 2008 and is headquartered in Santa Clara, California.
Sector: Medical - Devices
Industry: Medical - Devices
Minerva Surgical, Inc.
- 1:20Reverse splitOct 2, 202320 shares → 1
| Period | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Currency | USD | USD | USD | USD |
| Period Ending | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $50.29M | $52.1M | $37.77M | $26.01M |
| YoY Growth | -3.5% | 38.0% | 45.2% | - |
| Cost of Revenue | $23.05M | $21.58M | $18.65M | $14.21M |
| Gross Profit | $27.24M | $30.52M | $19.12M | $11.8M |
| Gross Margin | 54.2% | 58.6% | 50.6% | 45.4% |
| Research and Development | $5.44M | $5.29M | $3.32M | $935K |
| Selling, General, and Administrative | $52.7M | $54.38M | $31.19M | $30.51M |
| Other | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $58.14M | $59.67M | $34.51M | $31.44M |
| Operating Income (EBIT) | -$30.9M | -$29.14M | -$15.39M | -$19.64M |
| Operating Margin | -61.4% | -55.9% | -40.7% | -75.5% |
| Interest Expense | $3.22M | $11.73M | $12.14M | $17.58M |
| Interest Income | $89K | $10K | $81K | $135K |
| Other Income (Expense) | -$3.2M | $7.69M | -$3M | -$32.41M |
| Income Before Tax (EBT) | -$34.1M | -$21.45M | -$18.39M | -$52.05M |
| Income Tax Expense | $11K | $9K | -$132K | $0 |
| Net Income | -$34.11M | -$21.46M | -$18.26M | -$52.05M |
| Net Income Margin | -67.8% | -41.2% | -48.4% | -200.1% |
| Supplementary Data | ||||
| EPS | -23.68 | -14.98 | -17.91 | -75.29 |
| Diluted EPS | -23.68 | -14.98 | -17.91 | -75.29 |
| Weighted Average OS | 1.44M | 1.43M | 1.02M | 927,034 |
| EBITDA | -$20.07M | $893K | $821K | -$32.79M |
| EBITDA Margin | -39.9% | 1.7% | 2.2% | -126.1% |
| Period | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Currency | USD | USD | USD | USD |
| Period Ending | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | ||||
| Current Assets | ||||
| Cash and Cash Equivalents | $6.94M | $40.61M | $17.36M | $27.09M |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $6.94M | $40.61M | $17.36M | $27.09M |
| Accounts Receivable | $7.24M | $7.29M | $8.38M | $3.95M |
| Inventory | $16.85M | $15.68M | $10.2M | $4.74M |
| Other Current Assets | $1.36M | $7.43M | $7.57M | $7.37M |
| Total Current Assets | $36.12M | $75M | $45.42M | $43.81M |
| Long-Term Assets | ||||
| Property, Plant & Equipment Net | $5.31M | $4.59M | $2.88M | $2.27M |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangible Assets | $26.78M | $34.97M | $43.14M | $0 |
| Long-Term Investments | $265K | $524K | $604K | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $426K | $524K | $0 | $604K |
| Total Long-Term Assets | $32.78M | $40.09M | $46.63M | $2.87M |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $68.9M | $115.09M | $92.05M | $46.68M |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts Payable | $2.8M | $3.63M | $3.51M | $4.19M |
| Short-Term Debt | $1.89M | $189K | $1.67M | $0 |
| Current Income Tax Payable | $271K | $657K | $754K | $530K |
| Current Unearned Revenue | $339K | $206K | $219K | $51K |
| Other Current Liabilities | $3.7M | $8.61M | $18.33M | $2.66M |
| Total Current Liabilities | $14.28M | $22.81M | $33.27M | $15.22M |
| Long-Term Liabilities | ||||
| Long-Term Debt | $37.44M | $39.09M | $95.62M | $75.89M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $9.09M | $184.97M | $160.09M |
| Total Long-Term Liabilities | $37.44M | $48.37M | $280.59M | $235.99M |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Total Liabilities | $51.72M | $70.99M | $313.86M | $251.21M |
| Stockholders' Equity | ||||
| Preferred Stock | $0 | $0 | $0 | $0 |
| Common Stock | $29K | $28K | $1K | $1K |
| Retained Earnings | -$283.67M | -$249.56M | -$228.09M | -$209.83M |
| Comprehensive Income & Other | $11K | $11K | $11K | $11K |
| Other Stockholders' Equity | $300.82M | $293.63M | $6.28M | $5.3M |
| Total Equity | $17.18M | $44.1M | -$221.81M | -$204.52M |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $68.9M | $115.09M | $92.05M | $46.68M |
| Supplementary Data | ||||
| Total Debt | $39.69M | $39.27M | $97.29M | $75.89M |
| Net Debt | $32.75M | -$1.33M | $79.93M | $48.81M |
| Period | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Currency | USD | USD | USD | USD |
| Period Ending | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | ||||
| Net Income | -$34.11M | -$21.46M | -$18.26M | -$52.05M |
| Depreciation & Amortization | $10.81M | $10.62M | $7.08M | $1.68M |
| Deferred Income Tax | $0 | -$19.42M | -$132K | $14.95M |
| Stock-Based Compensation | $6.98M | $6.82M | $858K | $587K |
| Changes in Working Capital: | ||||
| Accounts Receivable | $48K | $1.09M | -$4.43M | -$332K |
| Inventory | -$4.13M | -$9.07M | $1.26M | $835K |
| Accounts Payable | -$881K | $3.3M | -$687K | -$2.98M |
| Other Working Capital | -$6.08M | -$3.86M | $990K | $368K |
| Total Working Capital Change | -$11.05M | -$8.55M | -$2.87M | -$2.11M |
| Other Non-Cash Items | -$8.19M | $9.62M | $1.08M | $17.16M |
| Net Cash from Operating | -$35.57M | -$22.38M | -$12.24M | -$19.79M |
| Investing Activities | ||||
| Capital Expenditures | -$73K | -$584K | -$453K | -$223K |
| Acquisitions | $0 | $0 | -$15M | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | -$25M | $0 | $0 |
| Net Cash from Investing | -$73K | -$25.58M | -$15.45M | -$223K |
| Financing Activities | ||||
| Debt Repaid | - | -$4.16M | -$17.96M | -$43.81M |
| Common Stock Issuance | $36K | $70.72M | $118K | $110K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$5M | -$3.67M | $0 | -$764K |
| Net Cash from Financing | -$4.96M | $71.21M | $18.08M | $43.16M |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$40.6M | $23.25M | -$9.62M | $23.14M |
| Supplementary Data | ||||
| Operating Cash Flow | -$35.57M | -$22.38M | -$12.24M | -$19.79M |
| Capital Expenditure | -$73K | -$584K | -$453K | -$223K |
| Free Cash Flow | -$35.64M | -$22.96M | -$12.69M | -$20.02M |
| Cash at Beginning | $48.41M | $25.17M | $34.78M | $11.64M |
| Cash at End | $7.81M | $48.41M | $25.17M | $34.78M |